Overexpression of RRM2 associated with genesis, progression of neuroblastoma [13], promotes tumorigenesis in glioblastoma [14, 15], glioma [16] and is a potential prognosis biomarker of these tumors [17–19]. Here, RRM2 is linked to neuroblastoma.